ACTSI Investigator Dr. Henry Blumberg in the News
Henry Blumberg, MD, ACTSI investigator, Research Education, Training, & Career Development (RETCD) program director, and professor of medicine and epidemiology, Division of Infectious Disease at Emory University School of Medicine
Emory News Center | NIH selects Emory-led partnership as one of four TB Research Units, with seven-year $18.7M grant
February 19, 2015
Dr. Henry Blumberg (Department of Medicine, Division of Infectious Diseases, Emory University) is a dual Principal Investigator of the Emory-led Tuberculosis Research Unit (TBRU), one of four new TBRUs funded by NIH's National Institute of Allergy and Infectious Diseases (NIAID) to create a TBRU network.
NIH News | NIH Expands Key Tuberculosis Research Program
February 18, 2015
Morehouse School of Medicine/Emory Collaboration T32 on Sleep Funded
Global Health: From Autism Screening to Neglected Tropical Diseases
Recent Publications:
"Latent tuberculous infection in the United States and Canada: who completes treatment and why?" Int J Tuberc Lung Dis. 2015 Jan;19(1):31-8.
Kipiani et al. "Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis." Clin Infect Dis. 2014 Dec 1;59(11):1559-66.
Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study." PLoS One. 2014 Oct 15;9(10):e108854.
"No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia." PLoS One 2014 Jan 21;9(1):e85698.